1. Home
  2. LPCN vs LFVN Comparison

LPCN vs LFVN Comparison

Compare LPCN & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.34

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$4.92

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPCN
LFVN
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.8M
51.5M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
LPCN
LFVN
Price
$2.34
$4.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
844.8K
98.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
3.51%
EPS Growth
46.18
226.09
EPS
N/A
0.19
Revenue
$1,976,677.00
$203,204,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$92.00
N/A
P/E Ratio
N/A
$26.89
Revenue Growth
N/A
1.86
52 Week Low
$1.81
$3.90
52 Week High
$12.37
$15.00

Technical Indicators

Market Signals
Indicator
LPCN
LFVN
Relative Strength Index (RSI) 30.02 60.87
Support Level N/A $3.99
Resistance Level $3.40 $5.37
Average True Range (ATR) 0.32 0.29
MACD -0.01 0.13
Stochastic Oscillator 7.01 65.84

Price Performance

Historical Comparison
LPCN
LFVN

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: